The Biden Administration finalizes new mental health parity rules for insurers. A large-scale study suggests that the active ingredient in the blockbuster weight loss medicine Ozempic reduced the risk of severe COVID reactions among patients with obesity. And, we’ll get some more top news in heathcare. That's coming up on today's episode of the Gist Healthcare podcast.
Hosted on Acast. See acast.com/privacy for more information.
